Say whatever you want about recreational cannabis, but the potential benefits to be had from the medical side are simply too good to pass up. Here's my top pick...

The tenth anniversary of this bull market came and went without much fanfare. But I think we've still got room to run, and I'm looking to this new sector for gains...

Even if a larger pharma company doesn't swoop in and acquire these biotech stocks for a fat premium, each and every one of them have the potential to deliver big gains for investors...

When you spot a company that's firing on all cylinders, then big-time returns are likely to follow. Here's why we're holding on for more...

There's no denying that small-cap stocks can provide investors with astronomical returns. But with our simple "hack," we can give ourselves an even better chance of finding a big-time winner...

The biggest winners don't always come from the usual places. So don't be surprised if one or more of these stocks find their way into my portfolio at some point down the road...

Most of our top picks for this year are already beating the market. But here's why it's not too late to get in on them right now...

The choice is simple. You can either stick with what you think is "safe," or you can learn about some of the fascinating technologies and companies everyone will be hearing about months from now -- and give yourself the chance for massive gains...

Identifying potential M&A targets is a difficult process, but the potential payoff can be worth the effort. Here are four big pharma companies that could be in the market for big deals in the near future...

Details on our highly-anticipated report, plus a free pick for you...